TRUP

TRUP
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $366.92M ▲ | $54.195M ▲ | $5.873M ▼ | 1.601% ▼ | $0.14 ▼ | $13.44M ▼ |
| Q2-2025 | $353.557M ▲ | $52.513M ▼ | $9.413M ▲ | 2.662% ▲ | $0.22 ▲ | $18.19M ▲ |
| Q1-2025 | $341.975M ▲ | $52.576M ▲ | $-1.483M ▼ | -0.434% ▼ | $-0.035 ▼ | $5.558M ▼ |
| Q4-2024 | $337.307M ▲ | $52.575M ▲ | $1.656M ▲ | 0.491% ▲ | $0.039 ▲ | $9.045M ▼ |
| Q3-2024 | $327.456M | $47.633M | $1.425M | 0.435% | $0.034 | $9.665M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $348.534M ▲ | $880.173M ▲ | $511.611M ▲ | $368.562M ▲ |
| Q2-2025 | $319.596M ▼ | $847.789M ▲ | $492.335M ▼ | $355.454M ▲ |
| Q1-2025 | $321.816M ▲ | $837.162M ▲ | $503.489M ▲ | $333.673M ▲ |
| Q4-2024 | $307.384M ▲ | $806.853M ▼ | $483.585M ▼ | $323.268M ▲ |
| Q3-2024 | $293.057M | $816.118M | $495.943M | $320.175M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $5.873M ▼ | $29.237M ▲ | $-2.321M ▲ | $-1.441M ▲ | $24.438M ▲ | $23.935M ▲ |
| Q2-2025 | $9.413M ▲ | $15.025M ▼ | $-42.467M ▼ | $-15.887M ▼ | $-41.539M ▼ | $12.049M ▼ |
| Q1-2025 | $-1.483M ▼ | $15.964M ▼ | $-8.973M ▼ | $-459K ▲ | $6.48M ▼ | $14.036M ▼ |
| Q4-2024 | $1.656M ▲ | $23.702M ▲ | $18.457M ▲ | $-1.674M ▼ | $38.659M ▲ | $21.844M ▲ |
| Q3-2024 | $1.425M | $15.295M | $-1.46M | $-1.039M | $13.278M | $13.382M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Other Operating Segment | $320.00M ▲ | $110.00M ▼ | $110.00M ▲ | $110.00M ▲ |
Subscription business | $440.00M ▲ | $230.00M ▼ | $240.00M ▲ | $250.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Trupanion is a fast-growing, still-unprofitable pet insurer that appears to be gradually tightening the gap between growth and profitability. Revenue and gross profit have risen strongly, and cash generation has improved, even though net income remains negative. The balance sheet looks reasonably healthy for a growth company, with rising assets, more cash than a few years ago, and only moderate use of debt. Its edge comes from deep ties with veterinarians, a rich data set, and a proprietary direct-pay platform that improves the customer and clinic experience. At the same time, the company operates in a competitive, evolving market and is pursuing multiple strategic initiatives—international expansion, tech upgrades, and broader pet health offerings—under new leadership. The central questions going forward are how effectively it can convert its competitive advantages into durable profitability and how well it can balance rapid growth with underwriting discipline and cost control.
NEWS
November 17, 2025 · 10:00 AM UTC
Trupanion's Commitment to Mission Highlighted as CEO Named 'Woman of Influence' by Puget Sound Business Journal
Read more
November 6, 2025 · 4:05 PM UTC
Trupanion Reports Strong Third Quarter 2025 Results and Secures New Credit Facility
Read more
November 4, 2025 · 10:00 AM UTC
Doubling Down for Canada's Pups: The Canadian Kennel Club and the Nation's Top Pet Insurer, Trupanion, Reaffirms Alliance to Give Puppies the Best Start
Read more
October 30, 2025 · 4:15 PM UTC
Trupanion Appoints Bradley Powell to Board of Directors
Read more
October 29, 2025 · 4:15 PM UTC
Trupanion Publishes 2025 Corporate Social Responsibility Report
Read more
About Trupanion, Inc.
https://www.trupanion.comTrupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $366.92M ▲ | $54.195M ▲ | $5.873M ▼ | 1.601% ▼ | $0.14 ▼ | $13.44M ▼ |
| Q2-2025 | $353.557M ▲ | $52.513M ▼ | $9.413M ▲ | 2.662% ▲ | $0.22 ▲ | $18.19M ▲ |
| Q1-2025 | $341.975M ▲ | $52.576M ▲ | $-1.483M ▼ | -0.434% ▼ | $-0.035 ▼ | $5.558M ▼ |
| Q4-2024 | $337.307M ▲ | $52.575M ▲ | $1.656M ▲ | 0.491% ▲ | $0.039 ▲ | $9.045M ▼ |
| Q3-2024 | $327.456M | $47.633M | $1.425M | 0.435% | $0.034 | $9.665M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $348.534M ▲ | $880.173M ▲ | $511.611M ▲ | $368.562M ▲ |
| Q2-2025 | $319.596M ▼ | $847.789M ▲ | $492.335M ▼ | $355.454M ▲ |
| Q1-2025 | $321.816M ▲ | $837.162M ▲ | $503.489M ▲ | $333.673M ▲ |
| Q4-2024 | $307.384M ▲ | $806.853M ▼ | $483.585M ▼ | $323.268M ▲ |
| Q3-2024 | $293.057M | $816.118M | $495.943M | $320.175M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $5.873M ▼ | $29.237M ▲ | $-2.321M ▲ | $-1.441M ▲ | $24.438M ▲ | $23.935M ▲ |
| Q2-2025 | $9.413M ▲ | $15.025M ▼ | $-42.467M ▼ | $-15.887M ▼ | $-41.539M ▼ | $12.049M ▼ |
| Q1-2025 | $-1.483M ▼ | $15.964M ▼ | $-8.973M ▼ | $-459K ▲ | $6.48M ▼ | $14.036M ▼ |
| Q4-2024 | $1.656M ▲ | $23.702M ▲ | $18.457M ▲ | $-1.674M ▼ | $38.659M ▲ | $21.844M ▲ |
| Q3-2024 | $1.425M | $15.295M | $-1.46M | $-1.039M | $13.278M | $13.382M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Other Operating Segment | $320.00M ▲ | $110.00M ▼ | $110.00M ▲ | $110.00M ▲ |
Subscription business | $440.00M ▲ | $230.00M ▼ | $240.00M ▲ | $250.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Trupanion is a fast-growing, still-unprofitable pet insurer that appears to be gradually tightening the gap between growth and profitability. Revenue and gross profit have risen strongly, and cash generation has improved, even though net income remains negative. The balance sheet looks reasonably healthy for a growth company, with rising assets, more cash than a few years ago, and only moderate use of debt. Its edge comes from deep ties with veterinarians, a rich data set, and a proprietary direct-pay platform that improves the customer and clinic experience. At the same time, the company operates in a competitive, evolving market and is pursuing multiple strategic initiatives—international expansion, tech upgrades, and broader pet health offerings—under new leadership. The central questions going forward are how effectively it can convert its competitive advantages into durable profitability and how well it can balance rapid growth with underwriting discipline and cost control.
NEWS
November 17, 2025 · 10:00 AM UTC
Trupanion's Commitment to Mission Highlighted as CEO Named 'Woman of Influence' by Puget Sound Business Journal
Read more
November 6, 2025 · 4:05 PM UTC
Trupanion Reports Strong Third Quarter 2025 Results and Secures New Credit Facility
Read more
November 4, 2025 · 10:00 AM UTC
Doubling Down for Canada's Pups: The Canadian Kennel Club and the Nation's Top Pet Insurer, Trupanion, Reaffirms Alliance to Give Puppies the Best Start
Read more
October 30, 2025 · 4:15 PM UTC
Trupanion Appoints Bradley Powell to Board of Directors
Read more
October 29, 2025 · 4:15 PM UTC
Trupanion Publishes 2025 Corporate Social Responsibility Report
Read more

CEO
Margaret Rosemary Maria Tooth
Compensation Summary
(Year 2024)

CEO
Margaret Rosemary Maria Tooth
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Price Target
Institutional Ownership

BLACKROCK INC.
5.452M Shares
$192.418M

BLACKROCK, INC.
5.16M Shares
$182.101M

CAPITAL WORLD INVESTORS
4.115M Shares
$145.205M

AFLAC INC
3.636M Shares
$128.327M

VANGUARD GROUP INC
3.554M Shares
$125.407M

FMR LLC
1.33M Shares
$46.936M

MAVERON GENERAL PARTNER III LLC
1.308M Shares
$46.168M

POLAR CAPITAL HOLDINGS PLC
1.3M Shares
$45.877M

BALYASNY ASSET MANAGEMENT L.P.
1.296M Shares
$45.732M

STATE STREET CORP
1.264M Shares
$44.593M

MARSHALL WACE, LLP
1.212M Shares
$42.777M

BANK OF AMERICA CORP /DE/
989.796K Shares
$34.93M

GEODE CAPITAL MANAGEMENT, LLC
865.703K Shares
$30.551M

MORGAN STANLEY
781.019K Shares
$27.562M

GREENLEA LANE CAPITAL MANAGEMENT, LLC
764.095K Shares
$26.965M

WELLINGTON MANAGEMENT GROUP LLP
647.919K Shares
$22.865M

MILLENNIUM MANAGEMENT LLC
619.003K Shares
$21.845M

DIMENSIONAL FUND ADVISORS LP
540.953K Shares
$19.09M

BLACKROCK FUND ADVISORS
492.837K Shares
$17.392M

CLEARBRIDGE INVESTMENTS, LLC
453.468K Shares
$16.003M
Summary
Only Showing The Top 20




